Manipulations that increase dopamine (DA) signaling can enhance fear extinction, but the circuits involved remain unknown. DA neurons originating in the substantia nigra (SN) projecting to the dorsal striatum (DS) are traditionally viewed in the context of motor behavior, but growing data implicate this nigrostriatal circuit in emotion. Here we investigated the role of nigrostriatal DA in fear extinction. Activation of SN DA neurons with designer G q -coupled receptors exclusively activated by designer drugs (G q -DREADD) during fear extinction had no effect on fear extinction acquisition, but enhanced fear extinction memory and blocked the renewal of fear in a novel context; a pattern of data paralleled by cFos expression in the central amygdala. D1 receptors in the DS are a likely target mediating the effects of SN DA activation. D1-expressing neurons in the medial DS (DMS) were recruited during fear extinction, and G q -DREADD-induced DA potentiated activity of D1-expressing neurons in both the DMS and the lateral DS (DLS). Pharmacological activation of D1 receptors in the DS did not impact fear extinction acquisition or memory, but blocked fear renewal in a novel context. These data suggest that activation of SN DA neurons and DS D1 receptors during fear extinction render fear extinction memory resistant to the disrupting effects of changes in contextual contingencies, perhaps by recruiting habitual learning strategies involving the DLS. Nigrostriatal DA thus represents a novel target to enhance long-term efficacy of extinction-based therapies for anxiety and trauma-related disorders.
INTRODUCTION
Extinction of traumatic memories is a major goal of therapeutic strategies for anxiety and trauma-related disorders, but extinction memories are labile and fear associated with traumatic memories can resurface even following successful extinction. Fear renewal is the return of conditioned responding following extinction in contexts different from that in which extinction occurred (Bouton and Ricker, 1994) and is a primary contributor to relapse (Goode and Maren, 2014) . Recent work has therefore focused on the neurocircuits underlying fear renewal (Chen et al, 2017; Knapska et al, 2012) , with a circuit involving ventral hippocampus, prefrontal cortex, and amygdala emerging as central to fear renewal (Wang et al, 2016; Knapska and Maren, 2009; Sotres-Bayon and Quirk, 2010) . Targeting this canonical circuitry with pharmacological or behavioral tools, however, has yielded mixed results in reducing renewal (Fitzgerald et al, 2014) . Identification of novel means to enhance fear extinction and prevent renewal is of utmost importance to mental health. Dopamine (DA) is a memory modulator implicated in fear extinction (Haaker et al, 2013; Abraham et al, 2014) . Recent theories proffer that fear extinction could involve learning a new association between the conditioned stimulus (CS) and a positive-affective state stemming from the relief that the predicted unconditioned stimulus (US) no longer follows the CS (Tronson et al, 2012) ; an association that could be supported by DA. Indeed, high-frequency (phasic) DA release in the striatum encodes both reward value (Howe et al, 2013) and prediction error (Schultz, 2016) . These functions of DA are traditionally thought to involve the mesolimbic DA pathway, originating in the ventral tegmental area (VTA) and terminating in the nucleus accumbens (NAc). Consistent with this view, phasic DA release in the NAc increases during fear extinction (Badrinarayan et al, 2012) , and D2 receptor signaling in the NAc has been reported to be necessary for fear extinction (Holtzman-Assif et al, 2010) . Emerging data indicate that functions of the nigrostriatal DA pathway, originating in the substantia nigra (SN) and terminating in the dorsal striatum (DS), overlap with those of mesolimbic DA (Kravitz and Kreitzer, 2012a; Wise, 2009) . Indeed, although nigrostriatal DA is traditionally viewed in the context of motor behavior, recent data reveal a role for the DS, particularly DS D1-expressing neurons preferentially responsive to phasic DA release (Dreyer et al, 2010) , in reinforcement (Kravitz et al, 2012b) and emotional behavior (Lenz and Lobo, 2013) . Despite potential involvement of multiple DA pathways in fear extinction, the effects of direct manipulations of nigrostriatal DA on fear extinction and renewal have yet to be investigated.
The goal of the current experiments was to begin to elucidate the role of nigrostriatal DA in fear extinction and renewal. Viral-mediated expression of designer G q -coupled receptors exclusively activated by designer drugs (G q -DREADD) and pharmacological approaches were used to test the hypothesis that activation of SN DA neurons and subsequent DS D1 receptor signaling can enhance fear extinction learning. Results suggest that nigrostriatal DA and DS D1 receptors could be a novel target for the prevention of fear relapse after extinction.
MATERIALS AND METHODS

Animals
A total of 43 adult, male Tg(TH-Cre)3.1Deis, Long-Evans rats were provided by Dr Karl Deisseroth via the National Institutes of Health Rat Resource and Research Center (Columbia, MO; Witten et al, 2011) and 88 adult, male wild-type Long-Evans rats (Charles River, Wilmington, MA) were pair-housed in Nalgene Plexiglass cages (45.5 W×24 D×21 H cm), in a temperature-(22°C) and humidity-controlled vivarium accredited by the Association for Assessment and Accreditation of Laboratory Animal Care located on the University of Colorado Denver Auraria campus. Rats were kept on a 12 h light-dark cycle with ad libitum access to food and water. Protocols were approved by the University of Colorado Denver institutional animal care and use committee.
Surgical Procedures
AAV5/hSyn-DIO-hm3D(G q )-mCherry (G q -DREADD) viral vector (University of North Carolina Gene Therapy Viral Core, Chapel Hill, NC; Zhu and Roth, 2014) was microinfused (1 μl/hemisphere; 0.1 μl/min) bilaterally into the SN pars compacta (−5.4 mm anterior, ± 2.3 mm lateral, − 8.8 mm ventral) of TH-Cre rats under Ketamine (75.0 mg/kg i.p.) and Medetomidine (0.5 mg/kg i.p.) anesthesia. Carprofen (5 mg/kg s.c.) for pain management and Penicillin G (22 000 IU/rat, s.c.) were administered at induction and every 24 h for 72 h after surgery. Behavioral tests were conducted 1 month after viral injection. Viral transfection in the midbrain was verified in all rats by inspection of mCherry (Olympus BX53; Center Valley, PA). Images through SN projection sites implicated in fear extinction were captured from at least 8 hemispheres per brain region per animal, and intensity of mCherry signal above background (densitometry) was calculated as previously described . Wild-type rats received bilateral 26-gauge guide cannula (4.6 mm below pedestal; Plastics One, Torrington, CT) targeted to the DS (+5.0 mm anterior, +3.0 mm lateral, − 4.5 mm ventral; Greenwood et al, 2012; Strong et al, 2011) and recovered for 1 week before behavioral testing.
Drugs
Clozapine-N-Oxide (CNO; National Institute of Mental Health Chemical Synthesis and Drug Supply Program, Bethesda, MD) was dissolved immediately before use in sterile saline with 0.6% DMSO (Boekhoudt et al, 2016) . Vehicle-treated rats received equal volume of 0.6% DMSO in saline. Vehicle or CNO (1 mg/kg i.p.) was administered 30 min before fear extinction training sessions. 2,3,4,5,-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine hydrochloride (SKF38393; 0.5 μg/μl; Agnoli et al, 2013; Sigma-Aldrich, St Louis, MO) and 6-chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide (SKF81297; 0.1 μg/μl; Larkin et al, 2016; Tocris Biosciences, Minneapolis, MN) were dissolved in sterile saline and microinjected into the DS (1 μl/hemisphere, rate of 0.5 μl/ min) through microinjectors extending 0.5 mm below the guide tip, 10 min before fear extinction.
Behavior
Auditory fear conditioning (4 CS-US presentations: 10 s, 80 dB, 2 kH auditory CS co-terminating with a 1 s, 0.8 mA foot shock, 1 min ITI), auditory fear extinction (20 CS; 1 min ITI), and fear renewal testing (4 CS; 1 min ITI) took place in contexts A, B, and C, respectively, following protocols used previously (Bouchet et al, 2017; Wang et al, 2016 ; see Supplementary Methods for details). ABC, as opposed to ABA, renewal was used to limit the contribution of contextual fear memory to fear expression during renewal. Although the use of a novel renewal context in the ABC renewal paradigm could increase susceptibility to external disinhibition, a novel renewal context was used to maintain consistency with prior work investigating renewal (Maren, 2014; Neumann and Kitlertsirivatana, 2010; Wang et al, 2016; Goode and Maren, 2014) .
Double-Label Fluorescent In Situ Hybridization
At 2 days following the renewal test, a subset of TH-Cre rats were injected i.p. with CNO (1 mg/kg) or vehicle and, 30 min later, either exposed to fear extinction or left in their home cages. Brains were processed with fluorescent in situ hybridization (FISH) for D1 and D2 mRNAs, or D1 and cfos mRNAs as previously described (Herrera et al, 2016; Mika et al, 2015) . Images (1.7 to − 0.8 mm Bregma) through the DMS, DLS, NAc core (NAcC), and NAc shell (NAcS) were captured on a confocal fluorescent microscope (200X, Axio Observer Z1; Zeiss Microscopy, Jena, Germany) from 4 distinct hemispheres from at least 2, but up to 4, brain sections. Single cfos, D1, D2, and double-labeled cells were counted by multiple experimenters blind to treatment conditions using Zeiss Zen software (Herrera et al, 2016; Mika et al, 2015) .
Statistical Analyses
Percent time spent freezing was calculated by averaging freezing data from individual experimenters with immobility times obtained from Noldus Ethovision XT. Pre-shock freezing for each test was averaged and group differences were analyzed with ANOVA. Average freezing across trials during conditioning and extinction were analyzed using repeated-measures ANOVA with subsequent Viral Expression Site or Drug as factors. Freezing across renewal trials was averaged and compared using 2 (Same vs Different) × 3 (DREADD study levels: Veh vs Off-Target CNO vs SN CNO; or D1 agonist study levels: Veh vs SKF38393 vs SKF81297) ANOVA. Group differences in cFos protein expression were analyzed with 2 × 3 ANOVA. Group differences in total number of cfos or D1 mRNA-expressing neurons and % D1-expressing neurons containing cfos mRNA were also analyzed with a 2 × 2 ANOVA. mCherry density between brain regions was analyzed with ANOVA. Fisher's protected least significant differences post hoc analyses were performed when appropriate. Group differences were considered significant when p ⩽ 0.05.
RESULTS
Activation of SN DA Neurons Enhances Fear Extinction Memory and Blocks Fear Renewal
Four rats had no visible mCherry and were excluded from analyses. Rats with mCherry expression restricted to at least one full SN hemisphere and no observable mCherry in the VTA were assigned after the experiment to the SN group (n = 16). Eight SN rats received CNO (SN CNO) and 8 received vehicle. Rats with minimal mCherry in the SN, but with visible mCherry in the VTA, were assigned to the OffTarget group. mCherry was observed in a portion of at least one hemisphere of the VTA in all 22 of the Off-Target rats. Twelve Off-Target rats were injected with CNO and 10 were injected with Vehicle. No significant differences were found between SN and Off-Target rats injected with Vehicle, and hence these rats were combined into the 'Vehicle' group (n = 18). Figure 1b depicts mCherry expression in brain regions of SN rats. A photomicrograph depicting terminal expression of mCherry in the DS is shown in Figure 1c . Of the mCherry-positive neurons, 92% were found to coexpress TH immunoreactivity (Figure 1d -f). Thus, although most of the viral transfection was restricted to DA-containing neurons, contribution of non-DA neurons to behavioral effects cannot be ruled out.
The G q -DREADD approach allows selective increases in phasic activation of discrete populations of DA neurons when the synthetic ligand CNO is injected i.p. (Alexander et al, 2009) . To determine the effects of G q -DREADDinduced SN DA activation during fear extinction on subsequent extinction memory and renewal, rats were injected with either vehicle or CNO during 2 days of fear extinction. Fear conditioning and fear renewal were conducted drug free (Figure 2a shows experimental timeline). Freezing was negligible before the first CS-US presentation during conditioning (Figure 2b ; pre). All rats acquired fear conditioning (Main effect of time: F(3, 105) = 16.421, po0.0001; Figure 2b ) and there was no difference in freezing between groups (Main effect of group: F(2, 25) = 2.2; p = 0.1). The post hoc analyses revealed that the SN CNO group did not differ from the Vehicle group during any of the conditioning trials, and only differed from the Off-Target CNO group during trial 4 (po0.05).
All groups displayed within-session fear extinction (Main effect of time: F(4, 140) = 55.004, po0.0001; Figure 2c ) that was similar between groups (Main effect of group: F (2, 35) = 0.6; p = 0.5). Average freezing during the first 2 fear extinction trials was almost identical between groups (F (2, 35) = 0.1; p = 0.9), indicating that the nonsignificant difference in freezing observed during fear conditioning did not result in differential fear memory between groups.
When tested for fear extinction memory, all rats displayed within-session fear extinction (Main effect of time: F (4, 140) = 26.45, po0.0001; Figure 2d ), but the SN CNO group displayed significantly less freezing than rats in other groups (Main effect of group: F(2, 35) = 3.22, p = 0.05; Figure 2d ), indicating enhanced fear extinction recall in rats whose SN DA neurons were activated during fear extinction. The interaction between viral expression and time just missed significance (F(8, 140) = 1.89, p = 0.06). The post hoc analyses indicated that the SN CNO group differed from the Off-Target CNO group during trials 2-4 and 14, and from the Vehicle group during trials 4, 9, and 18.
Rats were again exposed to the CS the next day in either the Same or a Different context for assessment of fear renewal. Significant fear renewal was noted in the Vehicle and Off-Target groups (main effect of context; F (1, 32) = 9.20, p = 0.005; Figure 2e ), but activation of SN DA neurons during extinction blocked fear renewal (Group by context interaction: F(2, 32) = 3.35; p = 0.04; Figure 2e ). Rats whose SN DA neurons were activated during fear extinction displayed altered neural activation patterns in regions important for contextual processing (CA1 of the hippocampus) and driving the fear response (CeA), but not in regions traditionally implicated in fear extinction memory, such as the IL of the PFC (Sotres-Bayon and Quirk, 2010; Knapska et al, 2012; Supplementary Figure S1 ).
Gq-DREADD Activates Target D1-Expressing Neurons in the DS
We used double D1/cfos FISH to determine whether the G q -DREADD approach successfully activates target D1-expressing neurons in the DS (see Figure 3a for regions counted). Virtually no colocalization of D1 and D2 mRNAs was observed in the DS (Figure 3b ). As almost all neurons in the DS express either D1 or D2 mRNA, cells expressing single cfos mRNA in the DS can be assumed to be putative D2-expressing neurons (Gerfen et al, 1990) .
A representative photomicrograph showing D1 and cfos mRNAs in the DMS of a rat exposed to extinction is depicted in Figure 3c . Extinction learning increased the percentage of D1-expressing neurons containing cfos mRNA in the DMS (F(1, 14) = 5.548, p = 0.03; Figure 3d ) and the number of single cfos mRNA-expressing cells in the DLS (F (1, 14) = 4.750, p = 0.04; Table 1 ). Fear extinction learning did not alter the number of single cfos mRNA-containing cells nor the percentage of D1-expressing neurons containing cfos mRNA in the NAcC or NAcS (Table 1) , but extinction learning increased the number of neurons expressing D1 mRNA in the NAcC (F(1, 14) = 4.634, p = 0.04; Table 1 ). Activation of G q -DREADD with CNO increased both the number of cells expressing cfos mRNA (F(1, 14) = 4.474, p = 0.05; Table 1 ) and the percentage of D1-expressing neurons containing cfos mRNA in the DMS (F (1, 14) = 13.492, p = 0.003; Figure 3d ) and the number of double-labeled D1/cfos mRNA-expressing neurons in the DLS (F(1, 16) = 5.564, p = 0.03; Figure 3d ), but had no effect in the NAcC or NAcS (Table 1 and Figure 3e ). We have previously observed that exposure to a familiar environment does not elicit appreciable Fos products in the striatum (Herrera et al, 2016) , and thus the cfos mRNA observed in the extinction group likely reflects an effect of fear extinction. 
Activation of DS D1 Receptors during Fear Extinction Blocks Fear Renewal without Enhancing Fear Extinction Memory
To determine the contribution of D1 receptors in the DS to the observed effects of G q -DREADD-induced activation of SN DA neurons, D1 agonists were microinjected into the DS before fear extinction learning on 2 subsequent days, and fear renewal was assessed drug free 24 h later (Figure 4a ). Because FISH revealed that the G q -DREADD approach activates target D1-expressing neurons in both the DMS and DLS, cannulae were targeted between the DMS and DLS. Given reports that systemic administration of SKF81297 and SKF38393 can differentially impact fear extinction (Abraham et al, 2016; Borowski and Kokkinidis, 1998) , we microinjected both drugs into the DS in different cohorts of rats before fear extinction. Out of 54 rats, 52 had successful bilateral DS cannulae (Figure 4j) , resulting in the following group sizes: Saline Same = 12, Saline Different = 11, SKF38393 Same = 8, SKF38393 Different = 9, SKF81297 Same = 6, and SKF81297 Different = 6. Rats acquired auditory fear conditioning equally (Main effect of time: F(3, 147) = 65.679, po0.0001; Figure 4b ), regardless of subsequent group assignment. Neither agonist affected freezing during the first fear extinction training session, during which all rats displayed within-session extinction (Main effect of time: F(4, 196) = 56.950, po0.0001; Figure 4c ). Similar effects were observed during the second fear extinction training session the next day (Main effect of time: F(4, 196) = 46.846, po0.0001; Figure 4d ). Freezing to the first few CS during a fear extinction session represents memory of previously acquired fear extinction (Do-Monte et al, 2015) , thus freezing during the first 4 trials were analyzed separately. Intra-DMS D1 agonist had no impact on fear extinction memory during the first 4 trials of the second fear extinction training session. Similarly, all rats displayed equivalent freezing in the Same context when tested drug free the next day. It is unlikely that the presence of the D1 agonist during the extinction memory test (extinction day 2; Figure 4d ) obscured a potential effect of prior D1 agonist on extinction memory, because similar results were observed in a different cohort of rats tested drug free a day after fear extinction in the presence of intra-DS SKF38393 (Supplementary Figure S2) .
Despite the observation that D1 activation had no effect on fear extinction learning or memory in the extinction context, rats that received D1 agonist before fear extinction were protected against fear renewal tested in a novel context 24 h after the second fear extinction training session (Drug by context interaction: F(2, 46) = 3.1, po0.0001; Figure 4e ). The post hoc tests revealed that the Saline Different rats froze more than all other groups, and neither the SKF38393 Different nor SKF81297 Different groups differed from their Same counterparts (Figure 4e ).
DISCUSSION
Data presented here reveal a novel role for nigrostriatal DA in fear extinction. Activation of SN DA neurons with G q -DREADD during fear extinction had no effect on fear extinction acquisition, but enhanced fear extinction memory and blocked the renewal of fear; a pattern of data paralleled by cFos expression in the CeA. D1-expressing neurons in the DS are a likely target mediating at least part of the effect of SN DA activation. Indeed, expression of terminal mCherry, indicating presence of G q -DREADD, was highest in the DS, D1-expressing neurons in the DMS were observed to be recruited during fear extinction, and G q -DREADD-induced DA potentiated activity of D1-expressing neurons in both the DMS and the DLS. Interestingly, rats whose SN DA neurons were activated by G q -DREADD during prior fear extinction displayed potentiated cFos expression in the CA1 of the hippocampus, a region important for contextual processing. Pharmacological activation of DS D1 receptors during fear extinction had no impact on fear extinction, but blocked fear renewal in a novel context. Together, these data suggest that activation of SN DA neurons and DS D1 receptors could render fear extinction memory resistant to memorydisrupting effects of changes in context, thus preventing fear renewal. Systemic manipulations that enhance DA signaling can enhance fear extinction and reduce relapse (Haaker et al, 2013; Abraham et al, 2014) , but prior work investigating the roles of specific DA circuits in fear extinction reveal inconsistent results. VTA DA neurons projecting to the PFC can impair fear extinction (Hitora-Imamura et al, 2015) ; however, other studies implicate involvement of D1 and D2 in the PFC in fear extinction (Hikind and Maroun, 2008; Mueller et al, 2010) . Midbrain DA neurons also provide DA innervation to other limbic structures including the BLA, hippocampus, and NAc. Although recent work elucidates a role for the BLA-NaC pathway in fear extinction (Correia et al, 2016) , DA manipulations in the BLA have no effect on fear extinction (Fiorenza et al, 2012; Hikind and Maroun, 2008) . In contrast, D1 activation in the hippocampus can enhance short-term fear extinction memory (Fiorenza et al, 2012) , whereas inhibition of D2 in the NAc has been reported to impair fear extinction (Holtzman-Assif et al, 2010) . Notably, relapse was not investigated in these studies; therefore, the effects of these manipulation on fear renewal is unknown. No studies to our knowledge have investigated the involvement of SN DA neurons and their primary target, the DS, in fear extinction.
Here we used a G q -DREADD approach in TH-Cre rats to selectively increase phasic activity of SN DA neurons (Zhu and Roth, 2014) . This approach was selective at targeting DA neurons in the SN (Figure 1 ) and produced a functional increase in activity of target DS D1-expressing neurons downstream of SN DA neurons (Figure 3d ). The effects of SN DA activation were not because of a nonspecific effect of DA on locomotor activity. Indeed, CNO did not alter general locomotor activity measured by spontaneous cage crossings in Context B before the first CS during either fear extinction training session (Supplementary Table S1 ), nor did CNO reduce freezing during the first extinction training day. These observations suggest that the reduced freezing displayed by the SN CNO group during extinction training day 2 was not due to an effect of CNO on the expression of freezing per se, but rather to SN DA facilitating the later recall of fear extinction. The effects of SN DA activation were also unlikely to be due to differential fear conditioning between groups. Indeed, freezing levels up to at least 84% can be detected during conditioning under these conditions (Supplementary Figure S2) , indicating that the lack of statistical difference between the SN CNO and Vehicle groups during conditioning was not due to a ceiling effect. Moreover, no group differences in fear memory were observed during the first few trials of extinction training day 1.
A critical question is where DA is acting to produce the observed effects of SN DA activation. Although the SN projects to regions other than just the DS, minimal terminal mCherry was observed in regions traditionally implicated in fear extinction, such as the PFC, hippocampus, and AMG. Therefore, it is unlikely that the observed effects of SN DA activation were mediated by DA in these regions, although a role for DA in these regions cannot be completely ruled out. Double FISH revealed that D1-expressing neurons in the DMS are recruited during fear extinction learning (Figure 3d ). DMS-cortical circuits are involved in guiding goal-directed behavior (Shiflett et al, 2010) that may increase as the animal acquires extinction and begins to evaluate the environment. We have observed potentiated activity of DMS D1-expressing neurons during recall of relapse-resistant fear extinction in rats that ran in wheels during fear extinction (Mika et al, 2015) . Together, these data suggest that DMS D1-expressing neurons could represent a previously unidentified component of fear extinction, recruitment of which could be involved in the learning or recall of fear extinction. In addition, although DLS D1-expressing neurons were not recruited during fear extinction, G q -DREADD-induced SN DA activity resulted in increased cfos in these DLS neurons (Figure 3d ). The DLS is involved in guiding inflexible behavioral strategies that can occur at the expense of goaldirected or spatial strategies (ie, 'habit'; Schwabe et al, 2008; Yin and Knowlton, 2006) . These data therefore raise the possibility that DA in the DLS elicited by G q -DREADD could have altered the learning strategy used during fear extinction acquisition to one involving the DLS. This is an intriguing possibility, as learning strategies involving the DLS may be less susceptible to the disruptive effects of contingency changes, such as context, during recall (Schwabe et al, 2008) . More selective targeting of DMS vs DLS DA circuits will be required to determine the role of DA in these regions in fear extinction. Similarly, how these DS regions communicate with canonical fear circuitry is currently unknown. The observation of altered cFos expression patterns during fear extinction memory recall in the CeA and CA1 (Supplementary Figure S1d and e) implicates these regions in the circuit through which nigrostriatal DA enhances fear extinction.
D1 agonists injected into the DS before fear extinction prevented fear renewal without affecting extinction memory (Figure 4e ), even when extinction memory was assessed drug free (Supplementary Figure S2) ; a pattern of data differing from that of SN DA activation. This discrepancy could be explained by phasic DA elicited by G q -DREADD interacting with DA receptors differently than receptor agonists. For example, phasic DA activates both D1-and D2-expressing neurons in the DMS (Table 1) , whereas the partial D1 agonist SKF38393 is selective to D1 (Conroy et al, 2015) . SKF81297, however, agonizes both D1 and D2 receptors (Rashid et al, 2007) . Another possibility is that DA in the DS could render extinction memories resistant to renewal, whereas DA in a different SN target could be responsible for enhancing extinction memory. As D1 agonists were targeted to the middle of the DS and the drugs likely spread to both the DMS and DLS, the effects of pharmacological D1 activation cannot shed light on where within the DS G q -DREADD-induced DA could have been acting. However, the pharmacological data do support the idea that nigrostriatal DA reduces fear renewal through a mechanism involving D1 receptors in the DS.
The current data demonstrate for the first time that augmenting activity of SN DA neurons can facilitation fear extinction memory. Importantly, fear extinction supported by nigrostriatal DA or DS D1 signaling is resistant to fear renewal. As relapse phenomena, including renewal, are a barrier to the long-term remission of anxiety and traumarelated disorders, the nigrostriatal DA pathway provides a promising target for the development of more effective therapeutic strategies.
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